FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/04/042245 [Registered on: 28/04/2022] Trial Registered Prospectively
Last Modified On: 26/07/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   prospective study of the incidence and risk factors of cystoid macular edema post vitrectomy for rhegmatogenous retinal detachment. 
Scientific Title of Study   Cystoid Macular Edema After Post Vitrectomy For Rhegmatogenous Retinal Detachment: A Prospective Study  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mukesh Jain 
Designation  Consultant, Vitreo-Retinal Services 
Affiliation  L V Prasad Eye Institute 
Address  Academic Block, First Floor Mithu Tulsi Chanrai Campus,
At-Patia Po-KIIT Bhubaneswar
Khordha
ORISSA
751024
India 
Phone  9786022417  
Fax  06742653130   
Email  jainmukesh@lvpei.org  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mukesh Jain 
Designation  Consultant, Vitreo-Retinal Services 
Affiliation  L V Prasad Eye Institute 
Address  Academic Block, First Floor Mithu Tulsi Chanrai Campus,
At-Patia Po-KIIT Bhubaneswar
Khordha
ORISSA
751024
India 
Phone  9786022417  
Fax  06742653130   
Email  jainmukesh@lvpei.org  
 
Details of Contact Person
Public Query
 
Name  Mohammed Hasibur Rahman  
Designation  Clinical Research Supervisor 
Affiliation  L V Prasad Eye Institute 
Address  Academic Block, Ground Floor Mithu Tulsi Chanrai Campus,
At-Patia Po-KIIT Bhubaneswar
Khordha
ORISSA
751024
India 
Phone  9937278658   
Fax  06742653130   
Email  hasiburrahman@lvpei.org  
 
Source of Monetary or Material Support  
Hyderabad Eye Research Foundation  
 
Primary Sponsor  
Name  Hyderabad Eye Research Foundation  
Address  L V Prasad Eye Institute Mithu Tulsi Chanrai Campus, Patia, Bhubaneswar  
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mukesh Jain  L V PRASAD EYE INSTITUTE  Academic Block, Ground Floor Clinical Research Department Mithu Tulsi Chanrai Campus Patia Bhubaneswar
Khordha
ORISSA 
9786022417
06743987130
jainmukesh@lvpei.org 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, L V Prasad Eye Institute   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H338||Other retinal detachments, (2) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Prednisolone Eye Drops (1%)   Prednisolone Eye Drops (1%)- 4 Times a day for duration of 3 weeks.  
Intervention  Dorzolamide Eye Drops (2%)  Dorzolamide Eye Drops (2%)-3 Times a day for duration of 3 weeks 
Comparator Agent  NA  NA 
Intervention  Nepafenac Eye Drops (0.1%)  Nepafenac Eye Drops(0.1%)- 3 times a day for duration of 3 weeks 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Age 18 to 70 years
2. All cases of rhegmatogenous retinal detachments
which undergo pars-plana vitrectomy using 23 g
vitrectomy system.
3. Follow up for 6 months following cataract
surgery.
4. Only cases with Silicone oil tamponade/ SF6
injection will be taken to facilitate
the post-operative OCT in follow up. 
 
ExclusionCriteria 
Details  1. Patients with retinal vascular disorders
2. Patients with uveitis
3. Patients with myopic retinoschisis
4. Patients with AMD or PCV or other macular conditions unrelated to retinal
detachment.
5. With co-existing retinal dystrophies
6. Case with combined retinal detachment 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To study the incidence and risk factors of the cystoid macular edema post
vitrectomy for rhegmatogenous retinal detachment 
Post-operative 3 weeks, 3 months
and 6 months. 
 
Secondary Outcome  
Outcome  TimePoints 
INCIDENCE OF ER POST PPV IN RD S  3 MONTHS 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/05/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   CME POST CATARATC SURGERY LEADS TO SUB-OPTICAL OUTCOMES. THE INCIDENCE OF THE SAME POST VITRECTOMY HAS NOT BE PROSPECTIVELY STUIDED. WE AIM TO STUDY THE INCIDENCE AND RISK FACTORS FOR THE SAME POST PPV IN RHEGMATOGENOUS RD  
Close